The companies that survive will look less like pyramids and more like swarms: small, autonomous AI-first pods that move and learn faster and execute relentlessly.

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs ...

Measuring the electron affinity, a fundamental chemical property, has been challenging for rare elements due to sensitivity limitations. Here, the authors present a novel ion-trap technique capable of ...